Join us as John D. Shakow, Partner, King & Spalding, provides his expert viewpoint on the latest changes and expected developments affecting drug pricing, price reporting and government compliance.  

John D. Shakow is a leading attorney and thought leader, specializing in drug pricing. John’s practice focuses on complex regulatory, commercial and litigation issues related to all aspects of drug pricing, price reporting, and government payor program compliance. He counsels a diverse group of pharmaceutical and biotechnology manufacturer clients on all pricing-related rights and obligations under the Medicaid, Medicare, Federal Supply Schedule, 340B and TRICARE programs. John advises on compliance, strategic planning, contract negotiation, merger integration, internal investigations, civil litigation and defense in government investigations. He regularly assists clients in interactions with government regulators, policymakers, commercial partners and industry groups. He has extensive experience helping clients resolve commercial and organizational challenges while maintaining the integrity of their price reporting compliance efforts.